CD44 and hepatocellular carcinoma: Fusion of hepatoma (HepG2) cells and embryonic stem cells (ESCs) produces more tumorigenic fusion cells, which are similar to TSCs, with enhanced expression of the TSC markers CD133, ALDH1 and CD44 [35].